Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-01-09 @ 3:30 AM
Study NCT ID:
NCT06419205
Status:
WITHDRAWN
Last Update Posted:
2025-04-20
First Post:
2024-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Sponsor:
Q32 Bio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-08
First Submit QC Date:
None
Study First Post Date:
2024-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-16
Last Update Post Date:
2025-04-20
Last Update Post Date Type:
ACTUAL